Dr Harold R Reeve, MD | |
668 Main St, Ste 4, Lumberton, NJ 08048 | |
(609) 267-6800 | |
(609) 267-8932 |
Full Name | Dr Harold R Reeve |
---|---|
Gender | Male |
Speciality | Urology |
Location | 668 Main St, Lumberton, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003887787 | NPI | - | NPPES |
0386997000 | Other | AMERIHEALTH | |
0016431 | Other | AETNA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | MD067331L (Pennsylvania) | Secondary |
208800000X | Urology | 25MA03602100 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Harold R Reeve, MD 668 Main St, Ste 4, Lumberton, NJ 08048 Ph: (609) 267-6800 | Dr Harold R Reeve, MD 668 Main St, Ste 4, Lumberton, NJ 08048 Ph: (609) 267-6800 |
News Archive
A new study published in Infectious Diseases of Poverty aimed to systematically evaluate the effectiveness and safety of the COVID-19 vaccines in the real world as well as establish a reliable evidence-based basis to determine the actual protective effect of the COVID-19 vaccines, especially considering the new waves of infection brought about by the variants.
A study by scientists at The Scripps Research Institute has helped to de-mystify the molecular workings of the multiple sclerosis (MS) drug Tecfidera. The drug is the most widely prescribed pill-based therapy for MS, but its biological mechanism remains mysterious.
TWi Pharmaceuticals, Inc. today announced that it launched its generic version of Par Pharmaceutical's MEGACE ES (megestrol acetate oral suspension) 625mg/5ml after the United States District Court for the District of Maryland reinstated its finding that United States Patent No. 7,101,576 (the '576 Patent) is invalid.
A rare and often underreported form of stroke that involves veins instead of arteries is more common than previously thought, according to the American Heart Association's first scientific statement on diagnosing and managing cerebral venous thrombosis (CVT).
› Verified 4 days ago